Literature DB >> 15869463

Activation of hepatocyte growth factor by urokinase-type plasminogen activator is ionic strength-dependent.

Wendy M Mars1, Minji Jo, Steven L Gonias.   

Abstract

The hepatocyte growth factor (HGF) is a multifunctional cytokine that is produced as latent scHGF (single chain HGF). Various proteases reportedly cleave scHGF to generate the active two-chain form (HGF), including u-PA (urokinase-type plasminogen activator), t-PA (tissue-type plasminogen activator), kallikrein, Factor XIa, Factor XIIa, HGF activator and matriptase. Considerable evidence indicates that, in vivo, u-PA activates scHGF in the liver; however, the in vivo results have not been uniformly supported by in vitro experiments. We now report that cleavage of scHGF by high-molecular-mass u-PA (abbreviated u-PA throughout) is sensitive to ionic strength. scHGF cleavage by u-PA was accelerated as the ionic strength was decreased. This result was equivalent irrespective of whether the predominant anion was chloride or acetate. Lmw-u-PA (low-molecular-mass u-PA) was ineffective at cleaving scHGF, regardless of ionic strength. Although scHGF shares homology with plasminogen, EACA (-amino-caproic acid) did not regulate u-PA-mediated scHGF cleavage. Soluble HGF receptor (MET) and soluble u-PAR (u-PA receptor) inhibited the scHGF cleavage. These results support a model in which the ability of u-PA to activate scHGF in vivo may be highly dependent on local conditions within the extracellular space.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15869463      PMCID: PMC1184584          DOI: 10.1042/BJ20042028

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  40 in total

1.  Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers.

Authors:  H Sakata; H Takayama; R Sharp; J S Rubin; G Merlino; W J LaRochelle
Journal:  Cell Growth Differ       Date:  1996-11

Review 2.  Ion transport in hepatocytes: mechanisms and correlations to cell volume, hormone actions and metabolism.

Authors:  J Graf; D Häussinger
Journal:  J Hepatol       Date:  1996       Impact factor: 25.083

3.  Presence of urokinase in serum-free primary rat hepatocyte cultures and its role in activating hepatocyte growth factor.

Authors:  W M Mars; T H Kim; D B Stolz; M L Liu; G K Michalopoulos
Journal:  Cancer Res       Date:  1996-06-15       Impact factor: 12.701

4.  Primary structure of rat HGF receptor and induced expression in glomerular mesangial cells.

Authors:  Y Liu; E M Tolbert; A M Sun; L D Dworkin
Journal:  Am J Physiol       Date:  1996-09

5.  Amino acids of the recombinant kringle 1 domain of human plasminogen that stabilize its interaction with omega-amino acids.

Authors:  G J Hoover; N Menhart; A Martin; S Warder; F J Castellino
Journal:  Biochemistry       Date:  1993-10-19       Impact factor: 3.162

6.  Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA.

Authors:  W M Mars; R Zarnegar; G K Michalopoulos
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

Review 7.  The Met-HGF/SF autocrine signaling mechanism is involved in sarcomagenesis.

Authors:  J Cortner; G F Vande Woude; S Rong
Journal:  EXS       Date:  1995

8.  Immediate early detection of urokinase receptor after partial hepatectomy and its implications for initiation of liver regeneration.

Authors:  W M Mars; M L Liu; R P Kitson; R H Goldfarb; M K Gabauer; G K Michalopoulos
Journal:  Hepatology       Date:  1995-06       Impact factor: 17.425

9.  Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction.

Authors:  L Naldini; E Vigna; A Bardelli; A Follenzi; F Galimi; P M Comoglio
Journal:  J Biol Chem       Date:  1995-01-13       Impact factor: 5.157

10.  Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator.

Authors:  T Shimomura; K Miyazawa; Y Komiyama; H Hiraoka; D Naka; Y Morimoto; N Kitamura
Journal:  Eur J Biochem       Date:  1995-04-01
View more
  6 in total

1.  Regulation of proteinases during mouse peri-implantation development: urokinase-type plasminogen activator expression and cross talk with matrix metalloproteinase 9.

Authors:  M G Martínez-Hernández; L A Baiza-Gutman; A Castillo-Trápala; D Randall Armant
Journal:  Reproduction       Date:  2010-11-12       Impact factor: 3.906

2.  Ah Receptor Pathway Intricacies; Signaling Through Diverse Protein Partners and DNA-Motifs.

Authors:  D P Jackson; A D Joshi; C J Elferink
Journal:  Toxicol Res (Camb)       Date:  2015-03-17       Impact factor: 3.524

3.  Coexpression of Smad7 and UPA attenuates carbon tetrachloride-induced rat liver fibrosis.

Authors:  Baocan Wang; Wenxi Li; Yingwei Chen; Yuqin Wang; Chao Sun; Yuanwen Chen; Hanming Lu; Jiangao Fan; Dingguo Li
Journal:  Med Sci Monit       Date:  2012-10

4.  Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor.

Authors:  Kumar Shanmukhappa; Gregg E Sabla; Jay L Degen; Jorge A Bezerra
Journal:  BMC Gastroenterol       Date:  2006-11-29       Impact factor: 3.067

5.  E4 engages uPAR and enolase-1 and activates urokinase to exert antifibrotic effects.

Authors:  Shailza Sharma; Tomoya Watanabe; Tetsuya Nishimoto; Takahisa Takihara; Logan Mlakar; Xinh-Xinh Nguyen; Matthew Sanderson; Yunyun Su; Roger A Chambers; Carol Feghali-Bostwick
Journal:  JCI Insight       Date:  2021-12-22

6.  Herbal compound triptolide synergistically enhanced antitumor activity of amino-terminal fragment of urokinase.

Authors:  Yuli Lin; Nana Peng; Jianping Li; Hongqin Zhuang; Zi-Chun Hua
Journal:  Mol Cancer       Date:  2013-06-08       Impact factor: 27.401

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.